SC-4289
SC-4289
Main page
287038

SC-4289

logo
Community Hub0 subscribers
What are your thoughts?
Be the first to start a discussion here.
Be the first to start a discussion here.
SC-4289

SC-4289 is a synthetic nonsteroidal estrogen which, along with mytatrienediol (SC-6924; Manvene, Anvene), was developed in the late 1950s as a potential treatment for atherosclerosis in men but was never marketed.

The chemical structure of SC-4289 is the same as for methallenestril but differs in that it is the benzyl ether and not the methyl ether.

SC-4289 makes an appearance in the allenestrol patent, as well as a stand-alone compound in:

See all
User Avatar
No comments yet.